Fully funded Biomaterials and Cancer Research PhD studentship at the University of Sheffield

If you have any studentship opportunities for Regener8 members, please contact us.

Title: Employing Spectroscopic Analysis To Identify Chemical Changes Associated With Different Subtypes of Breast Cancer Tissue Samples

The Biomaterials Research group is a dynamic group of experienced basic scientists and clinicians with a wide range of interests ranging from tissue engineering to translational biomaterials science.

The project will be carried out in close collaboration with Sheffield Medical School. The student will investigate a range of breast cancer samples with different subtypes, for evaluation of how these tissues differ with respect to changes in their proteins, lipids and carbohydrates.

Breast cancer is increasing worldwide with the highest rates reported in affluent western societies (the risk ratio is approximately 1 in 8 to 1 in 12) and is now the most common cancer in the females in UK. In the 1970s around 5 out of 10 women with breast cancer survived the disease beyond five years. Now it's more than 8 out of 10.

Click here to read more.

Eligibility

Applicants should have, or expect to achieve, a minimum of an upper-second-class Honours
degree (2.1 or above) in chemistry, physics, biomaterials, biomedical science or related subject.
The award covers UK/EU fees and a stipend at the standard UK research rate of £13,590 per
annum. A prospective candidate should check the EPSRC's eligibility criteria prior to application.

Applications

Applications should be made using the on-line application form
http://www.shef.ac.uk/postgraduate/research/apply and should include an up-to-date CV with a covering letter. The covering letter must include a summary as to why you wish to apply for this particular studentship and how your interests and experience relate to the project.

Further details of the project can be obtained by contacting Dr Ihtesham ur Rehman
i.u.rehman@sheffield.ac.uk
Applications must be received by 1st July 2011.